KLF6 and plasma cell myeloma: Galectin-1 (LGALS1) release is a common feature of inflammatory cell death, including necroptosis (Russo et al., 2021), while KLF6 downregulation has been shown to rescue the death of bortezomib-resistant multiple myeloma cells (Raninga et al., 2016).